Discovery Toxicology
Safety Assessment
  • Preclinical, non-GLP, cardiovascular function characterization
    • ECGs, blood pressure, heart rate, and left ventricular pressure in telemeterized large and small animal models
  • Clinical convulsive risk preclinical strategies
    • Acute/ chronic EEG and convulsive threshold evaluations
  • Regulatory consultation on preclinical studies 
  • Safety margin characterizations relative to therapeutic effects (LO compound selection support)
  • Endocrine function evaluation (conscious/unrestrained rodents)
    • HPA axis, HPG axis, endocrine organ/tissue function
Home | Animal Welfare | Privacy Policy | Contact Us | Site Map | Investigators | Covance.Asia
RSS © Copyright 2013 Covance Inc. All rights reserved.